1 / 17

Matisse

Matisse Interactive group art therapy for people with schizophrenia: The Matisse study. www.awp.nhs.uk enabling and empowering people to reach their potential and live fulfilling lives Background Emerging evidence base (Crawford & Patterson, 2007)

Gabriel
Download Presentation

Matisse

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Matisse Interactive group art therapy for people with schizophrenia: The Matisse study. www.awp.nhs.uk enabling and empowering people to reach their potential and live fulfilling lives

  2. Background Emerging evidence base(Crawford & Patterson, 2007) Negative symptoms and social functioning respond less well to medication NICE guidelines find evidence that arts therapies are effective in reducing negative symptoms (2009) However; -Concerns about methodological quality of trials to date (Ruddy R & Milnes D, 2005) -No evidence on outcomes such as social functioning, quality of life, or cost effectiveness.

  3. Background • Interactive group art therapy • Psychotherapeutic approach that synthesises concepts from art and group therapies. • Aims to encourage open communication, self-expression and interaction through the use of art materials and the group context. • The combination of image making and reflection can enable a person to work through difficult feelings. • A safe and consistent environment. • A non directive therapeutic stance. • Dame D. Waller (1996; 2000)

  4. Art Therapy

  5. Art Therapy

  6. A Randomised Controlled Trial • Multicentre Art-Therapy in Schizophrenia Systematic Evaluation (MATISSE) • Single blind Randomised Controlled Trial (RCT) • group art therapy plus standard care • activity group plus standard care, and • standard care alone.

  7. Study History Funding £960K Study duration 3yr originally, extended 9 months Study centres 2 London, AWP and Belfast Sample size 419

  8. Study Aims Hypotheses: Among people with schizophrenia, interactive group art therapy is associated with improved: • global functioning and 2. cost effectiveness compared to attention control treatment or standard care alone. Inclusion Criteria: Schizophrenia (working diagnosis + Opcrit)

  9. Study Design Outcome measures include: • Global Assessment of Functioning (GAF) scale. • Positive and Negative Symptom Scale (PANSS); • Quality of Life questionnaire; • Social Functioning questionnaire; • the General Wellbeing Scale; • Adult Service Use Schedule; • Morisky Scale and a satisfaction with care questionnaire. • Outcomes assessed at: Baseline, 12 months and 24 months after randomisation.

  10. Study Design • Art therapy • Weekly groups (median 12 months) • Facilitator and co-facilitator • Max 8 per group • Activity Groups • Provide participants with an opportunity to meet socially with peers and undertake a range of activities in a relatively informal, yet structured environment • Participation in social and recreational activities with the support of ‘group leaders’

  11. Recruitment

  12. 12-month follow-up

  13. 24-month follow-up

  14. Success – Matisse Participants • Success dependent upon Matisse participants • Agree for notes to be screened • Provide Informed Consent • Discussing complex research issues • Agreeing to randomisation process • Completing baseline assessment • Attend groups • To meet with the researcher for FU assessments at 12 and 24 months

  15. Success – AWP clinical teams • Success dependent upon AWP clinical teams • Engage with and adopt Matisse study • Successful adoption of Matisse trial across Trust • Identify participants and make first contact • Confidentiality and consent • Help clarify the Working Diagnosis • Study eligibility defined on a case by case basis supported by staff • Rate studyoutcomes • Primary outcome measure (GAF) • Staff questionnaire • Support follow up with researcher at 12 and 24 months after randomisation • Provide up to date contact information • Arrange appointments where contact difficult • Assess lone working risk, even attend assessments

  16. Success – MHRN • Success dependent upon R&D hosted Mental Health Research Network (MHRN) • Clinical Studies Officer time to support recruitment of study participants. • Conducting FU assessments where researcher has been fully unblinded.

  17. Benefits • Opportunity for AWP service users to be offered an intervention that they may not have been offered outside of the study. • Provide an opportunity for participants to contribute to the evidence base by taking part in research. • Providing additional contact time for the service user with the Trust at baseline, 12 and 24 months via the researcher. • Provides the Trust with an opportunity to assess the effectiveness of an intervention within a gold standard model. • Provision of financial remuneration in the form of service support costs for staff involvement. • Provide an opportunity for Trust staff to get involved with the design and conduct of a national research project.

More Related